Benlysta Market Report 2026
Download Free Sample Buy Now
Benlysta Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Benlysta Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Benlysta Market Overview

• The Benlysta market growth in the historic period has been driven by limited effective sle therapies, biologic drug innovation

• Market expansion is supported by rising lupus diagnosis rates, expanded indications such as lupus nephritis

• Growth Driver: Autoimmune Disease Rise Boosts Demand For Benlysta In SLE Treatment

• Market Trend: Innovative Autoinjectors Enable At-Home Lupus Treatment Enhancing Convenience For Caregivers

• North America was the largest region in 2025.

What Is Covered Under Benlysta Market?

Benlysta refers to a biologic medication known as belimumab, which is used primarily for the treatment of systemic lupus erythematosus (SLE), an autoimmune disease. It works by targeting and inhibiting the BLyS protein to reduce the survival of B cells, thus helping decrease disease activity and organ damage, and is administered via intravenous infusion or subcutaneous injection.

The main types of benlysta administration include intravenous (IV) and subcutaneous (SC) methods. Intravenous (IV) refers to the administration of medications, fluids, or nutrients directly into a vein, allowing for rapid absorption into the bloodstream. Its clinical indications encompass systemic lupus erythematosus (SLE), lupus nephritis (LN), and others. Benlysta is utilized across various end users, including hospitals, clinics, home care settings, and specialty pharmacies, ensuring widespread accessibility and flexibility in treatment delivery.

Benlysta Market Global Report 2026 Market Report bar graph

What Is The Benlysta Market Size and Share 2026?

The benlysta market size has grown rapidly in recent years. It will grow from $2404.67 million in 2025 to $2677.94 million in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to limited effective sle therapies, biologic drug innovation, early belimumab approvals, specialist rheumatology adoption, unmet autoimmune treatment needs.

What Is The Benlysta Market Growth Forecast?

The benlysta market size is expected to see rapid growth in the next few years. It will grow to $4073.18 million in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to rising lupus diagnosis rates, expanded indications such as lupus nephritis, improved biologic access, stronger reimbursement support, increased specialist awareness. Major trends in the forecast period include growing adoption of targeted autoimmune therapies, expansion of biologic treatments in lupus care, shift toward long term disease modifying agents, increased use of subcutaneous administration, rising focus on organ damage prevention.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Benlysta Market Segmentation

1) By Route Of Administration: Intravenous (IV), Subcutaneous (SC)

2) By Clinical Indication: Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Other Related Conditions

3) By End Users: Hospitals, Clinics, Home Care Settings, Specialty Pharmacies

What Are The Drivers Of The Benlysta Market?

The increase in new cases of autoimmune diseases is expected to drive the benlysta market going forward. Autoimmune diseases refer to a group of conditions where the body's immune system mistakenly attacks its own healthy cells, tissues, and organs. The prevalence of autoimmune diseases is increasing due to factors such as better diagnosis, environmental triggers, lifestyle changes, genetic predisposition, and an aging population. Benlysta helps manage autoimmune diseases, particularly systemic lupus erythematosus (SLE), by targeting and inhibiting the B-lymphocyte stimulator (BLyS) protein, which plays a key role in the overactive immune response, thus reducing the survival of harmful B cells and preventing them from attacking healthy tissues, ultimately helping to control disease activity, reduce flare-ups, and improve patient outcomes. For instance, in March 2024, according to the National Health Council, a US-based nonprofit organization, autoimmune diseases reportedly impact around 50 million people in the United States, though this figure may underestimate the true prevalence due to diagnostic challenges. Worryingly, autoimmunity is on the rise, with some studies suggesting an annual increase ranging from 3% to 12%. Moreover, in February 2024, according to the National Library of Medicine, a US-based biomedical library, global incidence of autoimmune diseases increases by 19.1% annually, while the prevalence rises by 12.5% each year. Therefore, the increase in new cases of autoimmune diseases is driving the growth of benlysta industry.

The growth in healthcare expenditure is expected to drive the benlysta market. Healthcare expenditure refers to the total spending on medical goods and services, including hospital care, pharmaceuticals, and healthcare administration. It encompasses both public and private sector spending on the prevention, treatment, and management of health conditions. Healthcare expenditure is growing due to an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. Additionally, rising healthcare demands and inflation contribute to higher costs across the sector. Rising healthcare expenditure supports the Benlysta market by increasing investment in treatments for chronic autoimmune conditions like lupus, leading to higher demand for biologic therapies. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in the UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, the growth in healthcare expenditure is driving the benlysta industry.

Key Players In The Global Benlysta Market

Major companies operating in the benlysta market are GlaxoSmithKline plc

Global Benlysta Market Trends and Insights

Major companies operating in the Benlysta market are focusing on developing innovative solutions, such as autoinjectors, to improve treatment accessibility, adherence, and patient convenience. Autoinjectors are devices designed to deliver a precise dose of medication quickly and easily, often allowing patients or caregivers to self-administer therapy at home, reducing the need for clinic visits. For instance, in May 2024, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology company, announced the FDA approval of the Benlysta (belimumab) autoinjector for pediatric patients aged 5 years and older with systemic lupus erythematosus (SLE). This approval introduces the first at-home treatment option for children requiring belimumab, allowing subcutaneous administration and eliminating the need for clinical visits every four weeks. The new autoinjector offers enhanced convenience and flexibility for caregivers, addressing the severe impact lupus has on children, including higher organ damage rates.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the benlysta market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Benlysta Market?

The benlysta market consists of sales of products such as immune system modulators, infusion equipment and biologic drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Benlysta Market Report 2026?

The benlysta market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the benlysta industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Benlysta Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate CAGR of 11.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Route Of Administration, Clinical Indication, End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled GlaxoSmithKline plc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Benlysta Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Benlysta Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Benlysta Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Benlysta Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Adoption Of Targeted Autoimmune Therapies

4.2.2 Expansion Of Biologic Treatments In Lupus Care

4.2.3 Shift Toward Long Term Disease Modifying Agents

4.2.4 Increased Use Of Subcutaneous Administration

4.2.5 Rising Focus On Organ Damage Prevention

5. Benlysta Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Rheumatology Clinics

5.3 Specialty Pharmacies

5.4 Infusion Centers

5.5 Home Care Settings

6. Benlysta Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Benlysta Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Benlysta PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Benlysta Market Size, Comparisons And Growth Rate Analysis

7.3. Global Benlysta Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Benlysta Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Benlysta Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Benlysta Market Segmentation

9.1. Global Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous (IV), Subcutaneous (SC)

9.2. Global Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Other Related Conditions

9.3. Global Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Home Care Settings, Specialty Pharmacies

10. Benlysta Market Regional And Country Analysis

10.1. Global Benlysta Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Benlysta Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Benlysta Market

11.1. Asia-Pacific Benlysta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Benlysta Market

12.1. China Benlysta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Benlysta Market

13.1. India Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Benlysta Market

14.1. Japan Benlysta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Benlysta Market

15.1. Australia Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Benlysta Market

16.1. South Korea Benlysta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Benlysta Market

17.1. Western Europe Benlysta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Benlysta Market

18.1. UK Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Benlysta Market

19.1. Germany Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Benlysta Market

20.1. France Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Benlysta Market

21.1. Eastern Europe Benlysta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Benlysta Market

22.1. North America Benlysta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Benlysta Market

23.1. USA Benlysta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Benlysta Market

24.1. Canada Benlysta Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Benlysta Market

25.1. South America Benlysta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Benlysta Market

26.1. Middle East Benlysta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Benlysta Market

27.1. Africa Benlysta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Benlysta Market, Segmentation By Route Of Administration, Segmentation By Clinical Indication, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Benlysta Market Regulatory and Investment Landscape

29. Benlysta Market Competitive Landscape And Company Profiles

29.1. Benlysta Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Benlysta Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Benlysta Market Company Profiles

29.3.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

30. Global Benlysta Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Benlysta Market

32. Benlysta Market High Potential Countries, Segments and Strategies

32.1 Benlysta Market In 2030 - Countries Offering Most New Opportunities

32.2 Benlysta Market In 2030 - Segments Offering Most New Opportunities

32.3 Benlysta Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Benlysta Market, Overview Of Key Products - Product Examples
  • Table 2: Global Benlysta Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Benlysta Market, Supply Chain Analysis
  • Table 4: Global Benlysta Market, Major Raw Material Providers
  • Table 5: Global Benlysta Market, Major Resource Providers
  • Table 6: Global Benlysta Market, Major Manufacturers (Suppliers)
  • Table 7: Global Benlysta Market, Major Distributors And Channel Partners
  • Table 8: Global Benlysta Market, Key Technologies & Future Trends
  • Table 9: Global Benlysta Market, Major Trends
  • Table 10: Global Benlysta Market, Major End Users
  • Table 11: Global Benlysta Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Benlysta Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Benlysta Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Benlysta Market - TAM, US$ Billion, 2025
  • Table 15: Global Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Benlysta Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Benlysta Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Benlysta Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Benlysta Market - Company Scoring Matrix
  • Table 73: GlaxoSmithKline plc Financial Performance
  • Table 74: Global Benlysta Market, Competitive Benchmarking (In USD Billions)
  • Table 75: Global Benlysta Market, Competitive Dashboard
  • Table 76: Global Benlysta Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 77: Global, Benlysta Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 78: Global, Benlysta Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Table 79: Global, Benlysta Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

List Of Figures

    Figure 1: Global Benlysta Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Benlysta Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Benlysta Market, Supply Chain Analysis
  • Figure 4: Global Benlysta Market, Major Raw Material Providers
  • Figure 5: Global Benlysta Market, Major Resource Providers
  • Figure 6: Global Benlysta Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Benlysta Market, Major Distributors And Channel Partners
  • Figure 8: Global Benlysta Market, Key Technologies & Future Trends
  • Figure 9: Global Benlysta Market, Major Trends
  • Figure 10: Global Benlysta Market, Major End Users
  • Figure 11: Global Benlysta Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Benlysta Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Benlysta Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Benlysta Market - TAM, US$ Billion, 2025
  • Figure 15: Global Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Benlysta Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Benlysta Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Benlysta Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Benlysta Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Benlysta Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Benlysta Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Benlysta Market - Company Scoring Matrix
  • Figure 73: GlaxoSmithKline plc Financial Performance
  • Figure 74: Global Benlysta Market, Competitive Benchmarking (In USD Billions)
  • Figure 75: Global Benlysta Market, Competitive Dashboard
  • Figure 76: Global Benlysta Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 77: Global, Benlysta Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 78: Global, Benlysta Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030
  • Figure 79: Global, Benlysta Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

Metabolic Disorders Drugs Global Market Report 2022 – By Type (Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)), By Distribution Channel (Hospital Pharmacies, Retai...

Frequently Asked Questions

The Benlysta market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Benlysta market is expected to grow at a CAGR of 11.1% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Benlysta market Include, GlaxoSmithKline plc .

Major trend in this market includes: Innovative Autoinjectors Enable At-Home Lupus Treatment Enhancing Convenience For Caregivers. For further insights on this market. request a sample here

North America was the largest region in the benlysta market in 2025. The regions covered in the benlysta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us